Newron Pharmaceuticals
Via R. Lepetit
21040
Gerenzano
Tel: 39-02-9668131
Fax: 39-02-96681333
Website: http://www.newron.it/
Email: info@newron.it
202 articles about Newron Pharmaceuticals
-
Newron Pharma To Evaluate Burden Of Disease For Rett Syndrome Patients And Families
6/27/2016
-
Newron Pharma To Present STARS Trial Design At U.S. Rett Syndrome Symposium
6/16/2016
-
Newron Pharma To Present At The Jefferies 2016 Healthcare Conference In New York
5/25/2016
-
Newron Pharma Announces IND Approval For Sarizotan For Treatment Of Rett Syndrome
5/17/2016
-
Newron Pharma And Partner Zambon Support Parkinson's Disease Awareness Day 2016
4/11/2016
-
Newron Pharma Release: Ongoing Phase II Study Of Evenamide (NW-3509) May Suggest An Alternative Approach To The Treatment Of Schizophrenia
4/5/2016
-
FDA Wants Additional Evaluation of Newron Pharma's Xadago
3/30/2016
-
Newron Pharmaceuticals Release: Evenamide (NW-3509): Evidence Of Anti-Psychotic Efficacy As An Add-On To Antipsychotics In Ongoing Phase 2 Study May Suggest An Alternative Approach To The Treatment Of Schizophrenia
3/23/2016
-
Newron Pharmaceuticals Shareholders Support Advancing Key CNS Pipeline Projects
3/22/2016
-
Zambon And U.S. WorldMeds Partner To Bring Newron Pharmaceuticals’ Parkinson’s Disease Treatment Xadago (Safinamide) To The U.S.
3/17/2016
-
Newron Pharmaceuticals To Present At The 23rd Annual BioCentury Future Leaders In The Biotech Industry Conference In New York
3/7/2016
-
Newron Pharmaceuticals Reports 2015 Financial Results
3/1/2016
-
Newron Pharmaceuticals Supports Rare Disease Day And Joins Global Movement To Raise Awareness For Rare Diseases
2/29/2016
-
Newron Pharmaceuticals Supports Rare Disease Day And Joins Global Movement To Raise Awareness For Rare Diseases
2/29/2016
-
Newron Pharmaceuticals To Present 2015 Financial Results On March 1, 2016
2/26/2016
-
Newron Pharmaceuticals To Present At The 18th Annual BIO CEO & Investor Conference In New York
1/28/2016
-
Newron Pharmaceuticals To Present At The 8th Annual Biotech Showcase Conference In San Francisco
1/7/2016
-
Newron Pharmaceuticals Initiates U.S. Phase II Trial In Patients With Schizophrenia
12/2/2015
-
Newron Pharmaceuticals To Present At The 27th Annual Piper Jaffray Healthcare Conference
11/24/2015
-
Newron Pharmaceuticals Completes 5.4 Million USD/CHF Private Placement With U.S. Biotechnology/Healthcare Specialist Fund
11/20/2015